GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Entia Biosciences Inc (OTCPK:ERGO) » Definitions » Shares Buyback Ratio %

Entia Biosciences (Entia Biosciences) Shares Buyback Ratio % : -0.15 (As of May. 18, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Entia Biosciences Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Entia Biosciences's current shares buyback ratio was -0.15%.


Entia Biosciences Shares Buyback Ratio % Historical Data

The historical data trend for Entia Biosciences's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Entia Biosciences Shares Buyback Ratio % Chart

Entia Biosciences Annual Data
Trend Jul07 Jul08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Shares Buyback Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.37 -11.46 -86.96 -81.19 -0.15

Entia Biosciences Quarterly Data
Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16
Shares Buyback Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.42 -0.11 -0.01 -0.01 -0.01

Entia Biosciences Shares Buyback Ratio % Calculation

Entia Biosciences's Shares Buyback Ratio for the fiscal year that ended in Dec. 2016 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Dec. 2015 ) - Shares Outstanding (EOP) (A: Dec. 2016 )) / Shares Outstanding (EOP) (A: Dec. 2015 )
=(28.1073 - 28.1498) / 28.1073
=-0.15%

Entia Biosciences's Shares Buyback Ratio for the quarter that ended in Dec. 2016 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Sep. 2016 ) - Shares Outstanding (EOP) (A: Dec. 2016 )) / Shares Outstanding (EOP) (A: Sep. 2016 )
=(28.146 - 28.1498) / 28.146
=-0.01%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Entia Biosciences Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Entia Biosciences's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Entia Biosciences (Entia Biosciences) Business Description

Traded in Other Exchanges
N/A
Address
13565 South West Tualatin-Sherwood Road, Suite 800, Sherwood, OR, USA, 97140
Entia Biosciences Inc operates as a biotechnology company, is engaged in the development, production, and distribution of dietary supplements, nutraceuticals, and medical foods products, principally in the United States of America. It market nutraceutical products under the name GROH and SANO directly to the consumers online. It currently offers natural organic nutraceutical mushroom dietary supplement products, ImmuSANO, GlucoSANO, and GROH, which has been designed to nutritionally support hair follicles and nail beds. It derives its revenue from the sale of its GROH line and mushroom-based nutraceutical dietary supplement products and functional ingredients.
Executives
Carl J Johnson director, officer: President and CEO
Hausman Marvin S Md director, officer: Chairman, CSTO 825 THIRD AVE, 40TH FL, NEW YORK NY 10022
Anka Capital Ltd 10 percent owner ROOM 2204 22F WEST TOWER SHUN TAK CENTRE, 200 CONNAUGHT ROAD CENTRAL, SHEUNG WAN K3 -
Cheuk Ho Tam 10 percent owner ROOM 2204 22F WEST TOWER SHUN TAK CENTER, 200 CONNAUGHT ROAD CENTRAL, SHEUNG WAN K3 -
Wah On Wong 10 percent owner ROOM 2204 22F WEST TOWER SHUN TAK CENTER, 200 CONNAUGHT ROAD CENTRAL, SHEUNG WAN K3 -

Entia Biosciences (Entia Biosciences) Headlines